
How a Double-Glitch Strategy Could Stop FANCA-deficient cancers
Scientists have identified a key vulnerability in cancers with FANCA gene mutations. By blocking a protein called AURKA, researchers successfully forced these specific cancer cells to self-destruct in laboratory models.


